A detailed history of Radnor Capital Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Radnor Capital Management, LLC holds 7,495 shares of AMGN stock, worth $2.39 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
7,495
Previous 7,035 6.54%
Holding current value
$2.39 Million
Previous $2.2 Million 9.87%
% of portfolio
0.36%
Previous 0.67%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$309.38 - $337.38 $142,314 - $155,194
460 Added 6.54%
7,495 $2.42 Million
Q2 2024

Jul 12, 2024

BUY
$262.75 - $319.31 $19,706 - $23,948
75 Added 1.08%
7,035 $2.2 Million
Q4 2023

Jan 11, 2024

BUY
$255.7 - $288.46 $15,342 - $17,307
60 Added 0.87%
6,960 $2.01 Million
Q3 2023

Oct 12, 2023

BUY
$218.65 - $271.46 $1.51 Million - $1.87 Million
6,900 New
6,900 $1.85 Million
Q1 2023

Apr 06, 2023

BUY
$225.79 - $275.2 $42,900 - $52,288
190 Added 2.43%
8,000 $1.93 Million
Q4 2022

Jan 09, 2023

BUY
$229.03 - $291.01 $178,643 - $226,987
780 Added 11.1%
7,810 $2.13 Million
Q3 2022

Oct 12, 2022

BUY
$224.46 - $253.15 $164,529 - $185,558
733 Added 11.64%
7,030 $1.59 Million
Q2 2022

Jul 11, 2022

BUY
$230.71 - $256.74 $13,842 - $15,404
60 Added 0.96%
6,297 $1.53 Million
Q1 2022

Apr 25, 2022

SELL
$219.27 - $242.57 $16,445 - $18,192
-75 Reduced 1.19%
6,237 $1.51 Million
Q4 2021

Jan 20, 2022

BUY
$198.88 - $227.6 $1.26 Million - $1.44 Million
6,312 New
6,312 $1.42 Million
Q3 2021

Oct 26, 2021

SELL
$212.27 - $248.7 $468,479 - $548,880
-2,207 Closed
0 $0
Q4 2020

Jan 13, 2021

BUY
$216.38 - $257.67 $5,409 - $6,441
25 Added 1.15%
2,207 $507,000
Q3 2020

Nov 02, 2020

BUY
$234.65 - $260.95 $44,583 - $49,580
190 Added 9.54%
2,182 $555,000
Q2 2019

Jul 18, 2019

BUY
$166.7 - $195.41 $4,167 - $4,885
25 Added 1.27%
1,992 $367,000
Q2 2017

Aug 09, 2017

BUY
N/A
1,967
1,967 $339,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $171B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Radnor Capital Management, LLC Portfolio

Follow Radnor Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Radnor Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Radnor Capital Management, LLC with notifications on news.